Synergistic roles of Synaptotagmin-1 and complexin in calcium-regulated neuronal exocytosis
Abstract
Calcium (Ca2+)-evoked release of neurotransmitters from synaptic vesicles requires mechanisms both to prevent un-initiated fusion of vesicles (clamping) and to trigger fusion following Ca2+-influx. The principal components involved in these processes are the vesicular fusion machinery (SNARE proteins) and the regulatory proteins, Synaptotagmin-1 and Complexin. Here, we use a reconstituted single-vesicle fusion assay under physiologically-relevant conditions to delineate a novel mechanism by which Synaptotagmin-1 and Complexin act synergistically to establish Ca2+-regulated fusion. We find that under each vesicle, Synaptotagmin-1 oligomers bind and clamp a limited number of ‘central’ SNARE complexes via the primary interface and introduce a kinetic delay in vesicle fusion mediated by the excess of free SNAREpins. This in turn enables Complexin to arrest the remaining free ‘peripheral’ SNAREpins to produce a stably clamped vesicle. Activation of the central SNAREpins associated with Synaptotagmin-1 by Ca2+ is sufficient to trigger rapid (<100 msec) and synchronous fusion of the docked vesicles.
Introduction
The controlled yet rapid (sub-millisecond) release of neurotransmitters stored in synaptic vesicles (SVs) is central to all information processing in the brain (Südhof, 2013; Kaeser and Regehr, 2014; Rizo, 2018). Synaptic release of neurotransmitters relies on the efficient coupling of SV fusion to the triggering signal – action potential (AP)-evoked Ca2+ influx into the pre-synaptic terminal (Kaeser and Regehr, 2014; Südhof, 2013). SV fusion is catalyzed by synaptic SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins, VAMP2 on the vesicles (v-SNAREs) and Syntaxin/SNAP25 (t-SNAREs) on the pre-synaptic membrane (Söllner et al., 1993; Weber et al., 1998). On their own, SNARE proteins are constitutively active and intrinsically trigger fusion in the range of 0.5–1 s (Ramakrishnan et al., 2018; Ramakrishnan et al., 2019; Xu et al., 2016).
To achieve the requisite speed and precision of synaptic transmission, the nerve terminals maintain a pool of docked vesicles that can be readily released upon Ca2+ influx (Südhof, 2013; Kaeser and Regehr, 2014; Südhof and Rothman, 2009). The prevailing theory is that in a ‘release-ready’ vesicle, multiple SNARE complexes are firmly held (‘clamped’) in a partially assembled state. These ‘SNAREpins’ are then synchronously released by Ca2+ to drive fusion dramatically faster than any one SNARE alone (Rothman et al., 2017; Brunger et al., 2018; Volynski and Krishnakumar, 2018). Several lines of evidence suggest that two synaptic proteins, Synaptotagmin-1 (Syt1) and Complexin (Cpx) play a critical role in establishing Ca2+-regulated neurotransmitter release (Geppert et al., 1994; Xu et al., 2007; Bacaj et al., 2013; Yang et al., 2013; Huntwork and Littleton, 2007).
Synaptotagmin-1 is a SV-localized protein with a large cytoplasmic part containing tandem C2A and C2B domains that bind Ca2+ (Fuson et al., 2007; Sutton et al., 1995). It is well established that fast AP-evoked synchronous release is triggered by Ca2+ binding to Syt1 C2 domains (Brose et al., 1992; Geppert et al., 1994; Littleton et al., 1993). Genetic analysis shows that Syt1 also plays a crucial role in ‘clamping’ spontaneous release and Ca2+-evoked asynchronous release to ensure high fidelity of the Ca2+-coupled synchronous transmitter release (Xu et al., 2009; Bacaj et al., 2013; Littleton et al., 1993). Recently it has been demonstrated that C2B-driven self-oligomerization of Syt1 provides the structural basis for its clamping function (Wang et al., 2014; Bello et al., 2018; Tagliatti et al., 2019). Syt1 is also involved in initial stages of docking of SVs to the plasma membrane (PM), in part mediated by its interaction with the anionic lipids, phosphatidylserine (PS) and phosphatidylinositol 4, 5-bisphosphate (PIP2) on the PM (Honigmann et al., 2013; Parisotto et al., 2012; Park et al., 2012). Besides the membrane interaction, Syt1 also binds the neuronal t-SNAREs on the PM, both independently (primary binding site) and in conjunction with Complexin (tripartite binding site) (Zhou et al., 2015; Zhou et al., 2017; Grushin et al., 2019). The Syt1-SNARE interactions are important for Syt1 role in SV docking, clamping fusion and triggering Ca2+-dependent neurotransmitter release (Zhou et al., 2015; Zhou et al., 2017).
Complexin is a cytosolic α-helical protein that binds and regulates SNARE assembly (Chen et al., 2002; Kümmel et al., 2011; Li et al., 2011). Biochemical analyses reveal that Cpx catalyzes the initial stages of SNARE assembly, but then blocks complete assembly (Giraudo et al., 2009; Kümmel et al., 2011; Li et al., 2011). Physiological studies show that Cpx indeed clamps spontaneous fusion in invertebrate neurons (Huntwork and Littleton, 2007; Wragg et al., 2013; Cho et al., 2014), but its importance as a fusion clamp in mammalian neurons is still under debate (Yang et al., 2013; López-Murcia et al., 2019; Courtney et al., 2019). However, under all conditions, Cpx has been shown to facilitate vesicle priming and promote AP-evoked synchronous release (Yang et al., 2013; Yang et al., 2015; López-Murcia et al., 2019).
It is broadly accepted that Syt1 and Cpx are both involved in clamping spurious or delayed fusion events and synchronize neurotransmitter release to Ca2+-influx. However, there is presently no coherent understanding how these proteins assemble and operate together. To gain mechanistic insights into this process, a reductionist approach where the variables are limited, and components can be rigorously controlled is required. We recently described a biochemically-defined fusion system based on a pore-spanning lipid bilayer setup that is ideally suited for this purpose (Ramakrishnan et al., 2018). This reconstituted setup is capable of precisely tracking individual vesicle docking, clamping (delay from docking to spontaneous fusion) and Ca2+ triggered release at tens of milliseconds timescale (Coleman et al., 2018; Ramakrishnan et al., 2019). Critically, this setup allows us to examine these discrete sub-steps in the vesicular exocytosis process, independent of alterations in the preceding or following stages (Coleman et al., 2018; Ramakrishnan et al., 2019; Ramakrishnan et al., 2018).
Using the in vitro fusion system, we recently reported that under artificially low-VAMP2 conditions (~13 copies of VAMP2 and ~25 copies of Syt1 per vesicle), Syt1 oligomerization is both necessary and sufficient to establish a Ca2+-sensitive fusion clamp (Ramakrishnan et al., 2019). Here we extend this study to more physiologically-relevant conditions, using SV mimics reconstituted with ~25 copies of Syt1 and ~70 copies of VAMP2. We report that under these conditions, both Cpx and Syt1 oligomers are needed to stably clamp all SNARE complexes and the reversal of the Syt1 clamp is sufficient to achieve fast, Ca2+-triggered synchronized fusion.
Results
Synaptotagmin and complexin co-operate to clamp vesicle fusion
With the goal of approximating the physiological context, we chose a reconstitution condition for small unilamellar vesicles (SUV) resulting in an average of 74 copies and 25 copies of outward-facing VAMP2 and Syt1, respectively (Figure 1—figure supplement 1). We employed pre-formed t-SNAREs (1:1 complex of Syntaxin1 and SNAP-25) in the planar bilayers (containing 15% PS and 3% PIP2) to both simplify the experimental approach and to bypass the requirement of SNARE-assembling chaperones, Munc18 and Munc13 (Baker and Hughson, 2016; Rizo, 2018). In most of the experiments, we used fluorescently-labelled lipid (2% ATTO647-PE) included in the SUVs to track the docking, diffusion and fusion of individual SUVs (Figure 1A).
We initially focused on the kinetics of constitutive fusion to assess the ability of Syt1 and Cpx to ‘clamp’ SNARE-driven fusion in the absence of Ca2+. We monitored large ensembles of vesicles to determine the percent remaining unfused as a function of time elapsed after docking and quantified as ‘survival percentages’ (Figure 1B). Docked immobile vesicles that remained un-fused during the initial 10 min observation period were defined as ‘clamped’ (Ramakrishnan et al., 2019). Vesicles containing VAMP2 only (vSUV) that docked to the t-SNARE containing bilayer surface were mobile and a majority (>95%) spontaneously fused typically with a t1/2 ~ 1 sec post-docking (Figure 1B, Figure 1—figure supplement 2, Table 1, Table 2, Video 1).
Inclusion of wild-type Syt1 in the vesicles (Syt1-vSUVs) enhanced the vesicle docking rate, with ~8 fold increase in total number of docked vesicles (Figure 1C). The majority (~80%) of docked Syt1-vSUVs remained mobile on the bilayer surface and fused on an average ~5–6 s after docking (Figure 1B, Figure 1—figure supplement 2, Table 1, Table 2, Video 2). The remaining small fraction (~20%) were immobile and stably clamped. This is in stark contrast to our earlier finding under low-copy VAMP2 conditions wherein the bulk of the Syt1-vSUVs (>90%) were stably clamped (Ramakrishnan et al., 2019). The pronounced docking-to-fusion delay introduced by Syt1 (t1/2 ~5 sec for Syt1-vSUV compared to ~1 s for vSUV) suggests that under physiologically-relevant (‘normal’ VAMP copy number) conditions, Syt1 alone can meaningfully delay but not stably clamp fusion.
This unstable Syt1 clamp was stabilized by addition of Cpx (Figure 1B, Figure 1—figure supplement 2, Video 3). In the presence of 2 µM of soluble Cpx, all Syt1-vSUVs were immobile following docking (Figure 1B), and they rarely fused over the initial observation period (Figure 1B, Figure 1—figure supplement 2, Table 1, Table 2, Video 3). In fact, these vesicles remained stably docked up to 1 hr without fusing (Figure 1—figure supplement 3). Furthermore, Syt1 and Cpx together significantly increased (~18 fold) the total number of docked vesicles (Figure 1C). Thus, we find that Syt1 and Cpx act synergistically to increase the rate of vesicle docking and serve to effectively block fusion of the docked vesicles under resting conditions.
Addition of soluble Cpx (2 µM) alone produced a ~10 fold increase in the number of docked vesicles (Figure 1C) but did not change the behavior of the docked vSUVs (Figure 1B, Figure 1—figure supplement 2, Table 1, Table 2, Video 4). In the presence of Cpx alone, virtually all docked vSUVs fused spontaneously typically within 1–2 s (Figure 1A,B). This meant that Syt1 somehow synergizes with Cpx to form the overall fusion clamp.
Synaptotagmin and complexin establish fast, Ca2+-triggered vesicle fusion
We then investigated the effect of Ca2+ on the stably Syt1/Cpx-clamped vesicles (Figure 2). We estimated the time of arrival of Ca2+ at/near the docked vesicles using a lipid-conjugated Ca2+ indicator (Calcium green C24) attached to the planar bilayer (Figure 2—figure supplement 1). Influx of free Ca2+ (1 mM) triggered simultaneous fusion of >90% of the docked vesicles (Figure 2B, Video 5). These vesicles fused rapidly and synchronously, with a characteristic time-constant (τ) of ~110 msec following the arrival of Ca2+ locally (Figure 2C). This estimate is constrained by the temporal resolution limit (150 msec per frame) of our imaging experiment. Indeed, most of Ca2+-triggered fusion occurs within a single frame (Figure 2C). We thus suspect that the true Ca2+-driven fusion rate is <100 msec. Notably, the Syt1/Cpx clamped vesicles remained Ca2+-sensitive even 1 hr post-docking (Figure 1—figure supplement 3). Our data indicate that Syt1 and Cpx acting together synchronize vesicle fusion to Ca2+ influx and greatly accelerate the underlying SNARE-mediated fusion process (which typically occurs at a rate of ~1 s). We also tested and confirmed these findings with a content-release assay using sulforhodamine B-loaded SUVs (Figure 2—figure supplement 2) under similar experimental conditions. Overall, we find that Syt1 and Cpx act co-operatively to clamp the SNARE assembly process to generate and maintain a pool of docked vesicles that can be triggered to fuse rapidly and synchronously upon Ca2+ influx.
Synaptotagmin and complexin clamp different sets of SNARE complexes
We next examined if Syt1 and Cpx act on the same SNARE complexes sequentially or if they function separately to produce molecularly-distinct clamped SNAREpins under the same docked vesicles. To this end, we employed an accessibility-dependent competition assay (Figure 3). We washed Cpx out from stably clamped Syt1/Cpx vesicles (by dilution) in the absence or the presence of excess inhibitory soluble cytoplasmic domain of the t-SNARE complex (CDT). Cpx binds to half-zippered (clamped) SNAREpins with a Kd ~0.5 µM (Krishnakumar et al., 2011; Kümmel et al., 2011) and is therefore expected to freely dissociate when the bulk concentration of CPX is reduced well below that level. CDT will bind and sequester/inactivate any free VAMP2 on the vesicles and is also expected to effectively compete out bilayer-anchored t-SNAREs. This is because CDT can form fully-zippered SNARE complexes (stabilized by ~70 kBT) as compared to the half-zippered SNAREpins (~35 kBT) formed by bilayer-anchored t-SNAREs (Li et al., 2016). We reasoned that if Syt1 and Cpx act on the same SNARE complex, then CDT treatment (with Cpx wash-out) would irreversibly block all vesicle fusion. However, if Syt1 and Cpx clamp different SNARE complexes, then some SNAREpins might be sequestered/protected from CDT by Syt1, thereby keeping the vesicles clamped yet sensitive to Ca2+ influx.
We used fluorescently-labeled Cpx to test and confirm the near-complete washout of Cpx from the clamped Syt1/Cpx vesicles following the extensive (40X) buffer wash (Figure 3—figure supplement 1). Without CDT, the docked vesicles proceeded to fuse spontaneously following the buffer wash (Figure 3A, Figure 3—figure supplement 2). This further confirmed that both Syt1 and Cpx are needed to produce a stably clamped state. In the presence of CDT, most of the vesicles remained docked even after the removal of previously-bound Cpx by the buffer wash (Figure 3B, Figure 3—figure supplement 2). Subsequent addition of Ca2+ (1 mM) triggered rapid and synchronous fusion of the docked vesicles (Figure 3B, Figure 3—figure supplement 2), with fusion kinetics similar to the control experiments (Figure 2C). This implied that there are at least two types of clamped SNAREpins under a docked vesicle – those clamped by Syt1 (which are shielded from CDT) and others arrested by Cpx (which become accessible to CDT following the buffer wash-out). It further indicated that even though both Syt1 and Cpx are required to produce a stably ‘clamped’ vesicle, the activation of the Syt1-associated SNAREpins is sufficient to elicit rapid, Ca2+-synchronized vesicular fusion.
Molecular mechanism of synaptotagmin clamp and Ca2+ activation of fusion
Considering these findings, we sought to establish the molecular determinants of the Syt1 clamp and its reversal by Ca2+. To focus on the Syt1 component of the clamp, we tested the effect of specific Syt1 mutations using low copy VAMP2 conditions, i.e. SUVs containing ~13 copies of VAMP2 and ~25 copies of Syt1 (wild type or mutants) in the absence of Cpx. Consistent with our earlier report (Ramakrishnan et al., 2019), wild-type Syt1 (Syt1WT) alone was sufficient to produce stably-clamped vesicles under these conditions (Figure 4A, Table 3, Table 4). Selective disruption of Syt1-SNARE ‘primary’ binding using the previously described (Zhou et al., 2015; Zhou et al., 2017) mutations in Syt1 C2B domain (R281A/E295A/Y338W/R398A/R399A; Syt1Q) and t-SNARE SNAP25 (K40A/D51A/E52A/E55A/D166A; SNAREQ) abolished the Syt1 clamp (Figure 4A, Table 3, Table 4,), with >99% of the docked Syt1Q vesicles fusing constitutively in the 10 min observation period (Note: From this point onwards, the ‘primary’ site mutation is simply referred as Syt1Q). On the other hand, Syt1 mutations (L387Q/L394Q; Syt1LLQQ) that disrupt the hydrophobic interaction that is an integral part of the SNARE-Cpx-Syt1 ‘tripartite’ interface (Zhou et al., 2017) had no effect on the Syt1 clamp (Figure 4A, Table 3, Table 4). Destabilization of the Syt1 C2B oligomers with a point-mutation (F349A)(Bello et al., 2018) also abrogated the Syt1 clamp, wherein ~ 85% of docked Syt1F349A vesicles proceeded to fuse spontaneously (Figure 4A, Table 3, Table 4). However, disrupting Ca2+ binding to the C2B domain (D309A, D363A, D365A; Syt1DA) (Shao et al., 1996) had no effect on Syt1 clamping function, with all vesicles remaining un-fused (Figure 4A, Table 3, Table 4). This meant that Syt1 ability to oligomerize and bind SNAREpins via the primary binding site is key to its clamping function.
Addition of Ca2+ (1 mM) triggered rapid and synchronous fusion of all of the docked Syt1WT and Syt1LLQQ vesicles and the remaining minority fraction (~15%) of the ‘clamped’ Syt1F349A containing vesicles (Figure 4B). In fact, the docked Syt1F349A vesicles were indistinguishable in their behavior from Syt1WT vesicles, suggesting the Syt1 oligomerization is not critical for the Ca2+-activation mechanism. In contrast, docked vesicles containing the Ca2+-binding mutant (Syt1DA) never fused even after Ca2+-addition (Figure 4B). Similarly, Ca2+-influx failed to trigger the fusion of the residual (~1%) Syt1Q vesicles. However, the relatively small number of docked Syt1Q prior to Ca2+-influx precludes any meaningful quantitative analysis. Nonetheless, our data suggest that Ca2+-binding to the Syt1 C2B domain and its simultaneous interaction with the t-SNARE protein via the primary binding site is required for Ca2+-triggered reversal of the fusion clamp.
We also tested the effect of the Syt1 mutants using vesicles containing physiological VAMP2 and Syt1 copy numbers in the presence of 2 µM Cpx (Figure 5A, Table 5, Table 6). For all mutations tested, we observed immobile, stably docked vesicles (Figure 5A, Table 5, Table 6). Surprisingly, the Cpx-dependent clamp was observed even under conditions wherein the Syt1 clamp was absent (i.e. Syt1Q and Syt1F349A). Survival analysis revealed that both Syt1Q and Syt1F349A mutants introduce a meaningful delay in the overall fusion process albeit less than that observed with a stable Syt1 clamp (Figure 5—figure supplement 1). This implies that the kinetic delay introduced by Syt1, independent of its ability to clamp, is sufficient to enable Cpx to function as a fusion clamp, perhaps by providing time for Cpx to bind and block all SNAREpins.
However, the clamped Syt1Q and Syt1F349A vesicles were insensitive to Ca2+ and did not fuse following Ca2+ (1 mM) addition as opposed to the rapid and synchronous fusion observed with the majority of the Syt1WT and Syt1LLQQ vesicles (Figure 5B). Notably, a significant partial fraction (~25%) of the Syt1LLQQ vesicles remained un-fused even following Ca2+ addition (Figure 5B). This suggests that while the Syt1-Cpx-SNARE tripartite interface is not essential for establishing the fusion clamp, it is likely important in the Ca2+-triggering of fusion.
Taken together, our data indicate that (i) the Syt1 clamp and associated SNAREpins are critical for Ca2+-triggered fusion and (ii) Cpx, on its own, irreversibly blocks vesicle fusion. These conclusions are corroborated by Cpx washout (±CDT) experiments on the Syt1Q vesicles (Figure 5—figure supplement 2). Without CDT, Syt1Q vesicles fused spontaneously following the Cpx washout. In the presence of CDT, the Syt1Q vesicles remained docked following the buffer wash, but were insensitive to Ca2+ and failed to fuse following the addition of 1 mM Ca2+ (Figure 5—figure supplement 2). This denotes that in Syt1Q vesicles (and presumably in Syt1F349A vesicles), all SNAREpins are clamped by Cpx alone and become accessible to CDT block following the Cpx wash-out.
Discussion
Here we report that Syt1 and Cpx act concomitantly to clamp SNARE-driven constitutive fusion events (Figure 1). We find there are at least two distinct sets of clamped SNAREpins under every docked vesicle – a small population that is reversibly clamped by Syt1 oligomers and the remainder that is irreversibly blocked by Cpx. (Figure 3). These results taken together with the known structural and biochemical properties of Syt1 and Cpx prompts a novel ‘synergistic clamping’ mechanism.
We posit that the Syt1 C2B domain binds PIP2 (via the poly-lysine motif) on the PM and assembles into ring-like oligomeric structures (Bello et al., 2018; Wang et al., 2014; Zanetti et al., 2016). The Syt1 oligomers concurrently bind the t-SNAREs via the ‘primary’ interface (Zhou et al., 2015; Zhou et al., 2017; Grushin et al., 2019). The Syt1-t-SNARE interaction, which likely precedes the engagement of the v- and the t-SNAREs, positions the Syt1 such that it sterically blocks the full assembly of the associated SNAREpins (Grushin et al., 2019). The Syt1 oligomers in addition to creating a stable steric impediment could also radially restrain the assembling SNAREpins (Grushin et al., 2019; Rothman et al., 2017). It is worth noting in this configuration the helical extension of Syt1 C2B that forms the ‘tripartite’ interface with Cpx and SNAREs contacts the PM and is thus unavailable for tripartite binding (Rothman et al., 2017; Volynski and Krishnakumar, 2018; Grushin et al., 2019).
The Syt1 oligomers can bind and clamp only a small sub-set of SNAREpins (which we refer to as ‘central SNAREpins’) as the number of potential SNAREpins per SV far exceeds the Syt1 density (~70 copies of VAMP2 vs. ~20 copies of Syt1). We suggest that the remaining ‘peripheral’ SNAREs would then be unrestrained and can fully zipper to catalyze vesicle fusion, though at an impeded rate (Figure 1). It is tempting to speculate that the limited set of Syt1-clamped ‘central’ SNAREpins correspond physiologically to the six symmetrically organized protein densities that underlie each docked synaptic-like vesicle visualized by cryo-electron tomography analysis (Li et al., 2019). Indeed, this symmetrical organization depends on Syt1 oligomerization (Li et al., 2019).
Cpx potentially binds the SNARE complex only when the Syntaxin and VAMP2 are partially-assembled (Chen et al., 2002; Kümmel et al., 2011) and competitively blocks the complete zippering of the C-terminal portion of the VAMP2 SNARE motif (Kümmel et al., 2011; Li et al., 2011; Giraudo et al., 2009). It is well-established that the C-terminal portion of VAMP2 assembles with extraordinarily high energy and rate acting as the major power stroke to drive membrane fusion (Gao et al., 2012). Consequently, Cpx, on its own, is ineffective in clamping SNARE-driven vesicle fusion (Figure 1).
We envision that under physiological conditions, Syt1 sets the stage for Cpx to bind and clamp the ‘peripheral’ SNARE complexes. Syt1, in addition to fully-arresting the central SNAREpins, also kinetically hinders the assembly of the peripheral SNAREpins enabling Cpx to effectually arrest their complete zippering. In this manner, the sequential action of Syt1 and Cpx on different populations of SNAREpins would be involved in the generation of the stably docked, release-ready vesicles. Under each vesicle, Syt1 oligomers bind and clamp a small sub-set of available SNAREpins at the early stages of docking, which in turn enables Cpx to block the remainder of the SNAREpins. This molecular model would readily explain the importance of both Syt1 and Cpx in establishing the fusion clamp as evidenced in several genetic deletion studies (Bacaj et al., 2013; Geppert et al., 1994; Cho et al., 2014; Martin et al., 2011; Littleton et al., 1993; Yang et al., 2013).
We also report that the reversal of the Syt1 clamp is sufficient to drive rapid Ca2+-triggered fusion of the docked vesicles (Figure 2). It involves Syt1 C2B domain binding both Ca2+ and the SNARE complex (Figure 4). We have recently demonstrated that Ca2+-binding to Syt1 C2 domains induce a large-scale conformational rearrangement of the Syt1-SNARE complex on the lipid membrane surface, disrupting the pre-fusion clamped architecture (Grushin et al., 2019). This, in effect, reverses the Syt1 clamp, allowing the associated SNAREs to complete zippering and drive fusion. This implies that only a small fraction of available SNAREpins per vesicle (i.e. only those associated with Syt1) are involved in the Ca2+-activation process. This is consistent with the earlier reports that 2–3 SNARE complexes can be sufficient to facilitate Ca2+-evoked synchronous neurotransmitter release (Sinha et al., 2011; Mohrmann et al., 2010). Indeed, recent modeling studies considering the concept of mechanical coupling have predicted that an optimum of 4–6 SNAREpins is required to achieve sub-millisecond vesicular release (Manca et al., 2019).
There is a long-standing debate over the role of Cpx in establishing a fusion clamp (Yang et al., 2013; López-Murcia et al., 2019). We find that Cpx is an integral part of the overall clamping mechanism and Syt1 and Cpx play distinct roles in clamping different pools of SNAREpins. However, Cpx requires a kinetic delay (likely introduced by Syt1) to block vesicle fusion and this inhibition is not released by Ca2+. This raises the intriguing possibility that the Cpx clamp is not necessarily reversed during the Ca2+-activation process. The molecular details of the observed Cpx ‘clamp’ and its physiological relevance remains to be determined.
Overall, our data are in alignment with the emerging view that Syt1 plays a pivotal role in orchestrating Ca2+-regulated neurotransmitter release. Syt1 functions both as a fusion clamp and the principal Ca2+-sensor to establish Ca2+-regulation of vesicular fusion (Geppert et al., 1994; Littleton et al., 1993). Furthermore, Syt1, by virtue of self-assembling into oligomeric structures, also provides the molecular framework to organize the exocytic machinery into a co-operative structure to enable ultra-fast fusion (Li et al., 2019; Rothman et al., 2017; Volynski and Krishnakumar, 2018).
We have articulated the simplest hypothesis, considering discrete ‘central’ and ‘’peripheral’ SNAREpins associated with Syt1 and Cpx, respectively. However, it is easy to imagine that Cpx also binds the central SNAREpins. Indeed, recent X-ray crystal structure revealed that both Syt1 and Cpx can bind the same pre-fusion SNARE complex (Zhou et al., 2017). Cpx binding is also predicted to create a new Syt1 binding site (i.e. tripartite interface) on SNAREs. In our reconstituted setup, we find that this SNARE-Cpx-Syt1 ‘tripartite’ interface is not required to produce the fusion clamp but is likely involved in Ca2+ activation of fusion from the clamped state (Figure 5).
Since the SNARE-Syt1-Cpx tripartite interface is created only when the SNAREs are partially-assembled (i.e. when Cpx binds), it is possible that this interaction plays an auxiliary role in establishing the fusion clamp. As such, it can be bypassed in our biochemically-defined experimental setup. The tripartite interface might become more relevant in the pre-synaptic terminals (Zhou et al., 2017) where ~ 30% of Syt1 is present in the PM (Wienisch and Klingauf, 2006) and other Synaptotagmins could also participate in the tripartite interface (Rothman et al., 2017; Volynski and Krishnakumar, 2018; Zhou et al., 2017).
Indeed, we have postulated that such a ‘dual-clamp’ arrangement with Syt1 (from SV) occupying the ‘primary’ site and with Syt1 and Syt7 (from PM) competing for the ‘tripartite’ site (in conjunction with Cpx) could potentially explain the synergistic regulation of neurotransmitter release by different Syt isoforms (Rothman et al., 2017; Volynski and Krishnakumar, 2018). Such an arrangement could also potentially explain how Cpx could regulate Ca2+-evoked synchronous neurotransmitter release.
Physiologically, all three synaptic SNAREs (Syntaxin, SNAP-25 and VAMP2) are assembled into a SNAREpin in a concerted reaction involving chaperones Munc13 and Munc18 (Baker and Hughson, 2016; Rizo, 2018), the need for which is by-passed in our system by pre-assembled t-SNARE complexes. We imagine that these chaperones also function in a concerted manner with Syt1 and Cpx and have recently advanced a speculative model outlining how these proteins can co-operate to template SNAREpin assembly (Rothman et al., 2017). Moreover, lipid membranes may contribute to synergism or cooperativity between Syt1 and Cpx in both clamping the un-initiated fusion events and triggering rapid and synchronous fusion in response to Ca2+-influx.
As such, further studies with high temporal resolution involving detailed mutational and topological analysis of Syt1 and Cpx, along with the chaperones Munc13 and Munc18, is needed to establish pointillistic details of fast Ca2+-triggered SV fusion. Nonetheless, our data demonstrate that Syt1 and Cpx, along with SNARE proteins, form the minimal protein machinery that is necessary and sufficient to establish rapid Ca2+-regulated exocytosis.
Materials and methods
Materials
The following cDNA constructs, which have been previously described (Krishnakumar et al., 2013; Krishnakumar et al., 2011; Weber et al., 1998; Mahal et al., 2002), were used in this study: full-length VAMP2 (VAMP2-His6, residues 1–116); full-length VAMP24X (VAMP2-His6, residues 1–116 with L70D, A74R, A81D, L84D mutations), full-length t-SNARE complex (mouse His6-SNAP25B, residues 1–206 and rat Syntaxin1A, residues 1–288); soluble cytoplasmic domain of the t-SNAREs (CDT, mouse His6-SNAP25B, residues 1–206 and rat Syntaxin1A, residues 1–265); Synaptotagmin (rat Synaptotagmin1-His6, residues 57–421); and Complexin (human His6-Complexin 1, residues 1–134). All mutants including Syt1F349A (F349A); Syt1Q (R281A/E295A/Y338W/R398A/R399A); Syt1LLQQ (L387Q/L394Q); Syt1DA (D309A, D363A, D365A) and SNAREQ (SNAP25 K40A/D51A/E52A/E55A/D166A) were generated in the above described Syt1 and t-SNARE background respectively using the QuickChange mutagenesis kit (Agilent Technologies, Santa Clara, CA). Lipids, 1,2-dioleoyl -snglycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3- (phospho-L-serine) (DOPS), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2–1,3-benzoxadiazol-4-yl) (NBD-DOPE), phosphatidylinositol 4, 5-bisphosphate (PIP2) were purchased from Avanti Polar Lipids (Alabaster, AL). ATTO647N-DOPE was purchased from ATTO-TEC, GmbH (Siegen, Germany) and lipophilic carbocyanine DiD (1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindodicarbocyanine Perchlorate) was purchased from Thermofisher Scientific (Waltham, MA). Calcium Green conjugated to a lipophilic 24-carbon alkyl chain (Calcium Green C24) was custom synthesized by Marker Gene Technologies (Eugene, OR).
Protein expression and purification
Request a detailed protocolAll proteins (v- and t-SNAREs, Cpx, Syt1 wild type and mutants) were expressed and purified as described previously (Mahal et al., 2002; Krishnakumar et al., 2013; Krishnakumar et al., 2011; Weber et al., 1998). In brief, proteins were expressed in E. coli strain Rosetta2(DE3) (Novagen, Madison, WI) using 0.5 mM IPTG for 4 hr. Cells were pelleted and lysed using a cell disruptor (Avestin, Ottawa, Canada) in HEPES buffer (25 mM HEPES, 400 mM KCl, 4% Triton X-100, 10% glycerol, pH 7.4) containing 0.2 mM Tris(2-carboxyethyl) phosphinehydrochloride (TCEP), and 1 mM phenylmethylsulfonyl fluoride (PMSF). Samples were clarified using a 45Ti rotor (Beckman Coulter, Atlanta, GA) at 40 K RPM for 30 min and subsequently incubated with Ni-NTA resin (Thermofisher Scientific, Waltham, MA) overnight at 4°C. The resin was washed with HEPES buffer (for Cpx) or HEPES buffer supplemented with 1% octylglucoside (Syt1 and SNAREs). Protein was eluted using 350 mM Imidazole and the concentration was determined using a Bradford Assay (BioRad, Hercules, CA) with BSA as a standard. Syt1 was further treated with Benzonase (Millipore Sigma, Burlington, MA) at room temperature for 1 hr, followed by ion exchange (Mono S, AKTA purifier, GE) to remove DNA/RNA contamination. The purity was verified using SDS-PAGE analysis and all proteins were flash frozen and stored at −80°C with 10% glycerol without significant loss of function.
Liposome preparation
Request a detailed protocolt-SNAREs and VAMP2 (±Syt1) containing SUV were prepared using rapid detergent (1% Octylglucoside) dilution and dialysis method as described previously (Weber et al., 1998; Ji et al., 2010). VAMP2 (±Syt1) containing SUVs were subjected to additional purification on the discontinuous Nycodenz gradient. The lipid composition was 80 (mole)% DOPC, 15% DOPS, 3% PIP2% and 2% NBD-PE for t-SNARE SUV and 88% DOPC, 10% PS and 2% ATTO647-PE for VAMP2 (±Syt1) SUVs. To mimic physiological copy numbers of protein, we used an input of protein: lipid ratio as 1: 400 for t-SNARE, 1:100 for VAMP2 for physiological density, 1: 500 for VAMP2 at low copy number, and 1: 250 for Syt1. This was based on well-established parameters namely that the reconstitution efficiency for SNAREs and Syt1 is roughly 40–50% (densitometry analysis of the proteoliposomes) and only approximately 50–60% of the proteins are externally oriented (chymotrypsin protection analysis) (Ji et al., 2010; Ramakrishnan et al., 2019; Weber et al., 1998). Based on the densitometry analysis of Coomassie-stained SDS gels, we estimated vesicles at physiological density, contained 74 ± 4 and 26 ± 6 copies of outward-facing VAMP2 and Syt1 respectively (Figure 1—figure supplement 1) and vesicles at low copy number of VAMP2 contained 13 ± 2 and 26 ± 6 copies of outward-facing VAMP2 and Syt1 respectively.
Single vesicle fusion assay
Request a detailed protocolAll the single-vesicle fusion measurements were carried out with suspended lipid bilayers as previously described (Ramakrishnan et al., 2019; Ramakrishnan et al., 2018). Briefly, t-SNARE-containing giant unilamellar vesicles as prepared using the osmotic shock protocol (Motta et al., 2015) were busted on freshly plasma-cleaned Si/SiO2 chips containing 5 µm diameter holes in presence of HEPES buffer (25 mM HEPES, 140 mM KCl, 1 mM DTT) supplemented with 5 mM MgCl2. The bilayers were extensively washed with HEPES buffer containing 1 mM MgCl2 and the fluidity of the t-SNARE containing bilayers was verified using fluorescence recovery after photo-bleaching using the NBD fluorescence. In some experiments, we labeled the t-SNAREs with Alexa-488 and confirmed protein mobility as described previously (Ramakrishnan et al., 2018).
Vesicles (100 nM lipids) were added from the top using a pipette and allowed to interact with the bilayer for 10 min. We used the ATTO647-PE fluorescence to track vesicle docking, post-docking diffusion, docking-to-fusion delays and spontaneous fusion events. Fusion was attested by a burst and then rapid decrease in fluorescence intensity as the fluorescent PE from the vesicle diffuses away. The time between docking and fusion corresponded to the fusion clamp and was quantified using a ‘survival curve’ whereby delays are pooled together, and their distribution is plotted in the form of a survival function (Figure 1). After the initial 10 min interaction phase, the excess vesicles in the chamber were removed by buffer exchange (3x buffer wash) and 1 mM CaCl2 was added from the top to monitor the effect of Ca2+ on the docked vesicles. The number of fused (and the remaining un-fused) vesicles was estimated (end-point analysis)~1 min after Ca2+-addition.
All experiments were carried out at 37°C using an inverted laser scanning confocal microscope (Leica-SP5) equipped with a multi-wavelength argon laser including 488, diode lasers (532 and 641 nm), and a long-working distance 40X water immersion objective (NA 1.1). The emission light was spectrally separated and collected by photomultiplier tubes. To cover large areas of the planar bilayer and simultaneously record large ensembles of vesicles, the movies were acquired at a speed of 150 ms per frame. Accurate quantification and fate of each vesicles were analyzed using our custom written MATLAB script described previously (Ramakrishnan et al., 2018). The files can be downloaded from MATLAB Central at the following website: https://www.mathworks.com/matlabcentral/fileexchange/66521-fusion-analyzer-fas. Note: We excluded vesicles bound to the edge of the holes as they may not be representative of vesicles bound to the free-floating membrane. We thus used only the centrally-docked vesicles for analysis. We did not observe any change in ATTO-647-PE fluorescence for the vesicles that remain docked and un-fused during the observation period or post Ca2+-addition. Thus, we can rule out hemi-fusion diaphragm formation as a possible explanation for the observed ‘clamped’ or ‘un-fused’ state.
Single-vesicle docking analysis
Request a detailed protocolTo get an accurate count of the docked vesicles, we used VAMP2 protein with mutations in the C-terminal half (L70D, A74R, A81D and L84D; VAMP24X) that eliminates fusion without impeding the docking process (Krishnakumar et al., 2013). For the docking analysis, VAMP24X containing SUVs (vSUV4X) were introduced into the chamber and allowed to interact with the t-SNARE bilayer. After a 10 min incubation, the bilayer was thoroughly washed with running buffer (3x minimum) and the number of docked vesicles were counted. For an unbiased particle count, we employed a custom-written algorithm to count particles from top-left to bottom-right that ensures every spot is counted only once.
Calcium dynamics
Request a detailed protocolTo quantify the kinetics of Ca2+-triggered vesicle fusion, we used a Ca2+-sensor dye, Calcium Green conjugated to a lipophilic 24-carbon alkyl chain (Calcium Green C24) introduced in the suspended bilayer to directly monitor the arrival of Ca2+. Calcium green is a high-affinity Ca2+-sensor (Kd of ~75 nM) and exhibits a large fluorescent increase (at 532 nm) upon binding Ca2+. To accurately estimate the arrival of Ca2+ to/near the vesicles docked on the bilayer, we used confocal microscopy equipped with resonant scanner focused at or near the bilayer membrane and acquired movies at a speed of up to 36 msec per frame. We typically observed the fluorescence signal increase at the bilayer surface between about three frames (~100 msec) after Ca2+ addition (Figure 2—figure supplement 1). We therefore used 100 msec as the benchmark to accurately estimate the time-constants for the Ca2+-triggered fusion reaction.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files, including Source data 1.
References
-
Chaperoning SNARE assembly and disassemblyNature Reviews Molecular Cell Biology 17:465–479.https://doi.org/10.1038/nrm.2016.65
-
Molecular mechanisms of fast neurotransmitter releaseAnnual Review of Biophysics 47:469–497.https://doi.org/10.1146/annurev-biophys-070816-034117
-
Phosphatidylinositol 4,5-bisphosphate clusters act as molecular beacons for vesicle recruitmentNature Structural & Molecular Biology 20:679–686.https://doi.org/10.1038/nsmb.2570
-
A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growthNature Neuroscience 10:1235–1237.https://doi.org/10.1038/nn1980
-
Protein determinants of SNARE-mediated lipid mixingBiophysical Journal 99:553–560.https://doi.org/10.1016/j.bpj.2010.04.060
-
Molecular mechanisms for synchronous, asynchronous, and spontaneous neurotransmitter releaseAnnual Review of Physiology 76:333–363.https://doi.org/10.1146/annurev-physiol-021113-170338
-
A conformational switch in complexin is required for synaptotagmin to trigger synaptic fusionNature Structural & Molecular Biology 18:934–940.https://doi.org/10.1038/nsmb.2103
-
Conformational dynamics of calcium-triggered activation of fusion by synaptotagminBiophysical Journal 105:2507–2516.https://doi.org/10.1016/j.bpj.2013.10.029
-
Complexin cross-links prefusion SNAREs into a zigzag arrayNature Structural & Molecular Biology 18:927–933.https://doi.org/10.1038/nsmb.2101
-
Complexin activates and clamps SNAREpins by a common mechanism involving an intermediate energetic stateNature Structural & Molecular Biology 18:941–946.https://doi.org/10.1038/nsmb.2102
-
Calcium-independent stimulation of membrane fusion and SNAREpin formation by synaptotagmin IJournal of Cell Biology 158:273–282.https://doi.org/10.1083/jcb.200203135
-
SNAREpin assembly by Munc18-1 requires previous vesicle docking by synaptotagmin 1Journal of Biological Chemistry 287:31041–31049.https://doi.org/10.1074/jbc.M112.386805
-
Controlling synaptotagmin activity by electrostatic screeningNature Structural & Molecular Biology 19:991–997.https://doi.org/10.1038/nsmb.2375
-
Mechanism of neurotransmitter release coming into focusProtein Science 27:1364–1391.https://doi.org/10.1002/pro.3445
-
Synergistic control of neurotransmitter release by different members of the synaptotagmin familyCurrent Opinion in Neurobiology 51:154–162.https://doi.org/10.1016/j.conb.2018.05.006
-
Synaptotagmin-1 functions as a Ca2+ sensor for spontaneous releaseNature Neuroscience 12:759–766.https://doi.org/10.1038/nn.2320
-
A programmable DNA origami platform to organize SNAREs for membrane fusionJournal of the American Chemical Society 138:4439–4447.https://doi.org/10.1021/jacs.5b13107
Article and author information
Author details
Funding
National Institute of Diabetes and Digestive and Kidney Diseases (027044)
- James E Rothman
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
We thank Dr. Frederic Pincet for critical inputs during the design and development of this project. This work was supported by National Institute of Health (NIH) grant DK027044 to JER.
Copyright
© 2020, Ramakrishnan et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,016
- views
-
- 359
- downloads
-
- 44
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Structural Biology and Molecular Biophysics
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.
-
- Structural Biology and Molecular Biophysics
SCARF1 (scavenger receptor class F member 1, SREC-1 or SR-F1) is a type I transmembrane protein that recognizes multiple endogenous and exogenous ligands such as modified low-density lipoproteins (LDLs) and is important for maintaining homeostasis and immunity. But the structural information and the mechanisms of ligand recognition of SCARF1 are largely unavailable. Here, we solve the crystal structures of the N-terminal fragments of human SCARF1, which show that SCARF1 forms homodimers and its epidermal growth factor (EGF)-like domains adopt a long-curved conformation. Then, we examine the interactions of SCARF1 with lipoproteins and are able to identify a region on SCARF1 for recognizing modified LDLs. The mutagenesis data show that the positively charged residues in the region are crucial for the interaction of SCARF1 with modified LDLs, which is confirmed by making chimeric molecules of SCARF1 and SCARF2. In addition, teichoic acids, a cell wall polymer expressed on the surface of gram-positive bacteria, are able to inhibit the interactions of modified LDLs with SCARF1, suggesting the ligand binding sites of SCARF1 might be shared for some of its scavenging targets. Overall, these results provide mechanistic insights into SCARF1 and its interactions with the ligands, which are important for understanding its physiological roles in homeostasis and the related diseases.